AI assistant
STAAR SURGICAL CO — Director's Dealing 2022
Jun 18, 2022
31996_dirs_2022-06-17_92bd1259-6e08-47aa-a34a-52c8c5ae80b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-06-16
Reporting Person: FRINZI THOMAS G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-16 | Common Stock | M | 355 | $0.00 | Acquired | 3279 | Direct |
| 2022-06-16 | Common Stock | M | 1450 | $0.00 | Acquired | 4729 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | Common Stock Options | $62.10 | M | 2881 | Acquired | 2032-06-15 | Common Stock (2881) | Direct |
Footnotes
F1: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.
F2: The restricted shares vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date.
F3: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to his continued service through the vesting date.